Tela Bio Inc

Healthcare · Medical Devices

1.10$ -1.8% vs. previous close Closing price · As of: Oct 7, 2026

Statements

Balance Sheet

Tela Bio Inc (TELA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 60 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet TELA
Line item	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	–	–	27	27	27	29	23	68	59	98	92	86	78	74	69	63	55	51	80	68	59	94	87	78	72	60	53	87	77	68	62	81	70	60
Current Assets	11	–	23	23	17	25	18	64	55	94	89	83	75	71	66	59	50	46	74	62	54	89	82	72	63	51	44	78	70	61	56	76	64	54
Cash	-11	–	17	17	-17	18	11	45	41	85	81	74	66	60	54	44	33	28	54	42	30	65	58	47	37	26	17	53	43	35	30	51	40	30
Cash & Short-Term Investments	11	–	–	17	17	18	11	55	47	85	81	74	66	60	54	44	33	28	54	42	30	65	58	47	37	26	17	53	43	35	30	51	40	30
Receivables	–	–	1.3	1.3	1.9	1.9	2.3	2.8	2.0	2.6	2.6	2.7	2.8	3.5	3.6	4.2	4.3	5.3	5.7	6.6	6.7	7.9	8.1	9.7	10	9.4	12	10	12	13	13	10	9.7	9.6
Inventory	–	–	4.3	4.3	4.6	4.6	4.3	4.6	4.8	4.6	4.0	3.9	4.7	4.5	6.3	7.7	10	10	12	12	15	14	14	13	14	13	14	13	14	11	12	11	12	11
Property, Plant & Equipment	–	–	0.8	0.8	0.7	0.7	0.7	0.7	0.7	0.7	0.7	0.6	0.6	0.6	0.9	1.2	1.5	3.0	3.0	1.7	1.7	1.8	–	–	–	–	–	–	–	–	–	–	–	–
Intangible Assets	–	–	3.2	3.2	3.1	3.1	3.0	2.9	2.8	2.8	2.7	2.6	2.5	2.5	2.4	2.3	2.2	2.7	2.6	2.5	2.4	2.3	2.2	2.1	2.0	1.9	1.8	1.7	1.6	1.5	1.5	1.4	1.3	1.2
Total Liabilities	–	–	41	165	39	38	183	37	35	34	36	37	37	39	41	42	45	53	56	54	56	54	57	59	57	57	59	59	59	58	60	75	75	76
Current Liabilities	–	–	9.6	9.6	7.6	7.6	6.3	6.7	4.2	3.6	5.3	6.6	5.6	7.3	9.4	11	12	12	15	12	14	13	15	17	15	15	17	16	17	19	17	18	18	18
Short-Term Debt	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.6	0.6	0.6	0.6	0.5	0.5	3.9	0.5	–	0.5	0.5
Accounts Payable	–	–	3.4	3.4	2.1	2.1	1.7	3.2	1.4	0.9	1.0	0.7	1.0	1.3	2.3	2.4	5.7	2.2	4.9	1.5	5.2	2.3	3.1	1.7	3.4	2.3	2.5	2.1	4.0	1.7	2.4	2.3	3.9	2.9
Long-Term Debt	–	–	30	30	30	30	30	30	30	31	31	31	31	31	31	31	32	40	40	40	40	40	40	41	41	41	41	41	41	38	41	56	56	56
Shareholders' Equity	3.2	–	-138	-138	-14	-8.7	-160	31	24	63	56	49	42	35	28	20	10	-1.5	23	14	3.1	40	31	19	14	2.9	-6.3	28	18	9.2	1.6	6.3	-5.2	-16
Retained Earnings	–	–	-138	-138	-154	-154	-160	-168	-175	-181	-189	-197	-205	-213	-221	-230	-241	-254	-264	-274	-286	-297	-308	-321	-327	-339	-350	-359	-370	-380	-389	-398	-410	-421
Shares Outstanding	0.3	0.3	6.5	6.5	6.5	6.5	11	6.1	11	11	14	14	14	14	14	15	15	15	17	19	19	23	24	24	25	25	25	40	45	45	45	52	57	57

Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings